Aarti Pharmalabs announced that the 91th Annual General Meeting (AGM) of the company will be held on 7 August 2024.Powered by Capital Market - Live News

Net profit of Aarti Pharmalabs rose 52.20% to Rs 65.25 crore in the quarter ended March 2024 as against Rs 42.87 crore during the previous quarter ended March 2023. Sales rose 4.27% to Rs 505.77 crore in the quarter ended March 2024 as against Rs 485.06 crore during the previous quarter ended March 2023.For the full year,net profit rose 12.10% to Rs 216.90 crore in the year ended March 2024 as against Rs 193.49 crore during the previous year ended March 2023. Sales declined 4.76% to Rs 1852.61 crore in the year ended March 2024 as against Rs 1945.23 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales505.77485.06 4 1852.611945.23 -5 OPM %23.2416.49 -20.8417.58 - PBDT114.8774.79 54 373.73323.31 16 PBT95.7558.84 63 300.49260.77 15 NP65.2542.87 52 216.90193.49 12 Powered by Capital Market - Live News

Aarti Pharmalabs announced that the Board of Directors of the Company at its meeting held on 13 May 2024, has recommended a Final dividend of Rs.1 per share (i.e.20%), subject to the approval of the shareholders.Powered by Capital Market - Live News

Aarti Pharmalabs will hold a meeting of the Board of Directors of the Company on 13 May 2024.Powered by Capital Market - Live News

Aarti Pharmalabs announced that the Board of Directors of the Company at its meeting held on 7 February 2024, inter alia, have recommended the interim dividend of Rs 2 per equity Share (i.e. 40%) , subject to the approval of the shareholders.Powered by Capital Market - Live News